Utilisation pattern of fentanyl transdermal system in The Netherlands

Pharmacoepidemiology and Drug Safety
N S Breekveldt-PostmaR M C Herings

Abstract

To describe the utilisation pattern of TTS fentanyl in daily practice. A retrospective cohort study was performed with data from the Dutch PHARMO system, including medication and hospital admission records of 850,000 inhabitants of 25 Dutch cities. New starters of TTS fentanyl with at least two consecutive prescriptions in the period of 1 January 1996 through 31 December 2001 were included in the study cohort. Patients were distinguished in having non-cancer or cancer pain. About 61% of the patients suffered from non-cancer pain and 60% used other opioids before start of TTS fentanyl. The majority of the patients used other pain medication during the first treatment episode. Most patients (74%) started treatment with the lowest dose of TTS fentanyl (25 microg/hour), patients with cancer pain more often started with higher doses. About half of the patients changed type of patch during the first treatment episode, 80% of these patients had an increase in dose of TTS fentanyl. Fifty percent of all patients had a first treatment episode of less than 2 months and more than one third did not renew their prescription within two months. The median number of days of use per patch was 2.2 days for all patients. The use of TTS fentanyl is...Continue Reading

References

Apr 1, 1995·Anti-cancer Drugs·R PayneM Einhaus
Apr 1, 1996·Journal of Pain and Symptom Management·R K Portenoy
Jul 7, 1997·The Medical Journal of Australia·J R Bell
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R PayneR Mahmoud
May 2, 1998·Journal of Pain and Symptom Management·B DonnerM Raber
Sep 16, 1998·Journal of Pain and Symptom Management·P A SloanH Hays
Nov 6, 1998·Journal of Pain and Symptom Management·P L DellemijnJ A Vanneste
Sep 4, 1996·PharmacoEconomics·M J ZagariW C Longton
Feb 11, 2000·Clinical Pharmacokinetics·S GrondK A Lehmann
Feb 7, 2001·JAMA : the Journal of the American Medical Association·D E JoransonJ L Dahl
Sep 18, 2001·European Journal of Pain : EJP·P L Dellemijn
Jun 11, 2002·Palliative Medicine·L RadbruchK A Lehmann

❮ Previous
Next ❯

Citations

Jun 18, 2011·Pharmacoepidemiology and Drug Safety·Edeltraut GarbeUlrike Schmid
Oct 2, 2015·The Medical Journal of Australia·Svetla GadzhanovaLisa G Pont
Nov 6, 2018·European Journal of Clinical Pharmacology·Natasa GisevLouisa Degenhardt
Jun 14, 2017·International Journal of Clinical Pharmacy·Francisca N WagemaakersMieke L van Driel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Related Papers

The Journal of Pain : Official Journal of the American Pain Society
K MystakidouL Vlahos
Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Shefali AgarwalSrinivasa N Raja
The Journal of Pain : Official Journal of the American Pain Society
Boris ZernikowBrian Anderson
Palliative Medicine
Augusto CaraceniWorking Group of an IASP Task Force on Cancer Pain
© 2021 Meta ULC. All rights reserved